Allergy Therapeutics plc (LON:AGY – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of GBX 4.68 ($0.06) and traded as high as GBX 4.75 ($0.06). Allergy Therapeutics shares last traded at GBX 4.53 ($0.06), with a volume of 195,396 shares.
Allergy Therapeutics Stock Up 2.3 %
The firm has a 50 day simple moving average of GBX 4.68 and a two-hundred day simple moving average of GBX 4.04. The company has a quick ratio of 1.48, a current ratio of 1.40 and a debt-to-equity ratio of 37.22. The stock has a market capitalization of £220.85 million, a P/E ratio of -75.42, a PEG ratio of -30.70 and a beta of 1.40.
Allergy Therapeutics Company Profile
Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.
Featured Stories
- Five stocks we like better than Allergy Therapeutics
- Learn Technical Analysis Skills to Master the Stock Market
- The Average 401k Balance by Age Explained
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Profitably Trade Stocks at 52-Week Highs
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Allergy Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allergy Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.